Are Wall Street Analysts Bullish on Zimmer Biomet Stock?

Warsaw, Indiana-based Zimmer Biomet Holdings, Inc. (ZBH) operates as a medical technology company. It designs, manufactures, and markets orthopedic reconstructive products. With a market cap of $23 billion, Zimmer Biomet serves orthopedic surgeons, neurosurgeons, hospitals, healthcare dealers, and more.

The medical device manufacturer has substantially underperformed the broader market over the past year. Over the past 52 weeks, ZBH dipped 6.3% compared to the S&P 500 Index’s ($SPX) 28.1% returns. In 2024 alone, ZBH is down 8.3% versus SPX’s 17.3% gains on a YTD basis.